Skip to main content

Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment The State of the Science, Evaluation, Implementation, and Economics: Workshop Summary (2006) / Chapter Skim
Currently Skimming:

Appendix A Workshop Agenda
Pages 93-98

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 93...
... 8:45-10:15 am session 1 Brief overview of technologies moderator: howard schulman
Read the entire page →
From page 94...
... Michael Phelps, PhD (University of California, Los Angeles) 10:30 am-12:00 noon session II overcoming the technical obstacles moderator: charles sawyers Presentations: Informatics and data standards John Quackenbush, PhD (Harvard)
Read the entire page →
From page 95...
... Strategies for determining analytic validity and clinical utility of biomarkers Moderators -- Janet Woodcock, Howard Schulman, John Wagner Invited Discussants -- Walter Koch, Zoltan Szallasi, Scott Patterson, Ronald Hendrickson, David Carbone, Laura Reid 3) Clinical development strategies for biomarker utilization Moderators -- Charles Sawyers, Stephen Friend, David Parkinson, Richard Simon Invited Discussants -- Richard Schilsky, David Agus, Barbara Weber, Richard Frank, Robert Gillies
Read the entire page →
From page 96...
... Clinical laboratory diagnostic tests: Oversight for analytical and clinical validation Mark Heller, JD (Wilmer Cutler Pickering Hale and Dorr) Clinical trial design and biomarker-based tumor classification systems Richard Simon, DSc (National Cancer Institute)
Read the entire page →
From page 97...
... Mechanisms for developing an evidence base Moderators -- Janet Woodcock, David Parkinson, Charles Sawyers Invited Discussants -- Walter Koch, Indra Poola, Laura Reid, Richard Frank
Read the entire page →
From page 98...
... Incorporating biomarker evidence into clinical practice Moderators -- Robert McDonough, William McGivney Invited Discussants -- David Carbone, David Agus, Hongyue Dai, Mark Fendrick, Judith Hellerstein, Judith Wagner 5:15 pm adjourn day 2 day 3 -- march 22, 2006 reports from small group discussions 8:30-10:00 am reports from day 1 group leaders 10:15 am-12:15 pm reports from day 2 group leaders 12:15 pm wrap up/summary hal moses 12:30 pm lunch -- adjourn
Read the entire page →

Key Terms

  • charles sawyers
  • howard schulman
  • richard simon
  • implications surrounding
  • robert gillies

  • richard frank
  • barbara weber
  • david parkinson
  • william mcgivney
  • indra poola

  • hongyue dai
  • policy implications
  • laura reid
  • ann zauber
  • surrounding biomarker

  • discussions policy
  • david agus
  • cancer institute
  • wagner invited
  • funding initiatives

  • determining analytic
  • evaluation center
  • mcgivney invited
  • margaret spitz
  • technology evaluation

  • perspective naomi
  • scott patterson
  • tumor classification
  • sawyers invited
  • mark heller


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.